BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression

Therapeutic strategies aimed at harnessing anti-tumor immunity are being intensively investigated as they show promising results in cancer treatment. The PD-1/ PD-L1 pathway is an essential target for restoring functional anti-tumor immune response. BRD7 is a candidate tumor suppressor gene and nuclear transcription factor of nasopharyngeal carcinoma (NPC) which was cloned in our laboratory. In this paper, we reported that the candidate tumor suppressor gene BRD7 was strongly associated with good prognosis of NPC patients and negatively regulated PD-L1 expression. In addition, we found that BRD7 down-regulated PD-L1 expression and enhanced the killing function of CD8<sup>+</sup> T lymphocytes in NPC cells through binding to p85α via the 485-651 domain and inhibiting the activity of PI3K, thereby inhibiting the activity of PI3K/AKT/mTOR/STAT3 pathway. <i>In vivo</i> experiments, the results showed that BRD7 could not only inhibit the growth of tumors, but also play a better anti-tumor effect when combined with PD-L1 antibody. These results provided further evidence that BRD7 inhibited immune escape of NPC through down-regulating PD-L1 expression.

Authors

Institutions

Publication Details

Journal
International Journal of Biological Sciences
Published
2025-02-10
DOI
https://doi.org/10.7150/ijbs.103703
Citations
6
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
6.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression

Qing Zhou, Ying Liu, Xiaoxu Li, Zhaoyang Zeng et al.
6 citations
International Journal of Biological Sciences
Peptidase Inhibition and Analysis
6.27
article

BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression

Qing Zhou, Ying Liu, Xiaoxu Li, Zhaoyang Zeng, Ziying Tian, Jieyu Zhou, Ming Zhou, Mengna Li, Nan Li, Su Jiang, Shiqi Yan, Yilin Guo, Donghai Huang, Xiao Zhou, Guiyuan Li, Xiayu Li, Songqing Fan, Wei Xiong, Lei Shi, Jiaxue Lu, Wenling Zhang
article en
6 citations

Abstract

Therapeutic strategies aimed at harnessing anti-tumor immunity are being intensively investigated as they show promising results in cancer treatment. The PD-1/ PD-L1 pathway is an essential target for restoring functional anti-tumor immune response. BRD7 is a candidate tumor suppressor gene and nuclear transcription factor of nasopharyngeal carcinoma (NPC) which was cloned in our laboratory. In this paper, we reported that the candidate tumor suppressor gene BRD7 was strongly associated with good prognosis of NPC patients and negatively regulated PD-L1 expression. In addition, we found that BRD7 down-regulated PD-L1 expression and enhanced the killing function of CD8<sup>+</sup> T lymphocytes in NPC cells through binding to p85α via the 485-651 domain and inhibiting the activity of PI3K, thereby inhibiting the activity of PI3K/AKT/mTOR/STAT3 pathway. <i>In vivo</i> experiments, the results showed that BRD7 could not only inhibit the growth of tumors, but also play a better anti-tumor effect when combined with PD-L1 antibody. These results provided further evidence that BRD7 inhibited immune escape of NPC through down-regulating PD-L1 expression.

International Journal of Biological SciencesVol. 21(5)
Central South University (CN), Ministry of Education (SA), Zhengzhou City Hospital (CN), Second Xiangya Hospital of Central South University (CN), Third Xiangya Hospital (CN), Xiangya Hospital Central South University (CN)
Zero hunger
Openalex Percentile: Top 4%
Peptidase Inhibition and Analysis
6.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.